sixty degrees pharmaceuticals nasdaq sxtp investor webinar march 31 2025
1970-01-01
0
0
0
YouTube
Download
Convert to MP3
Loading...
Loading...
Related Videos
Inside 60 Degrees Pharma’s Vision: CEO Geoffrey Dow on Combatting Infectious Diseases (NASDAQ: SXTP)
60 Degrees Pharmaceuticals Reports Doubling of Q2 2024 Revenues and Advances Clinical Trials
Interview with Sixty Degrees Pharma (Nasdaq: SXTP) CEO Geoff Dow
DON'T BUY 60 Degrees Pharmaceuticals Stock (Until You Watch This Analysis) #SXTP
An Exclusive Look at Sixty Degrees Pharma (Nasdaq: SXTP) with CEO Geoff Dow
60 Degrees Pharmaceuticals, sxtp stock analysis buy or sell
60 Degrees Pharmaceuticals, Inc.: Developing New Medicines for Infectious Diseases
POTENTIAL SQUEEZE : SXTP STOCK ANALYSIS | 60 DEGREES PHARMACEUTICALS INC STOCK
